EATONTOWN, N.J., Sept. 25 /PRNewswire-FirstCall/ -- Osteotech, Inc.
(Nasdaq: OSTE), a leader in the emerging field of biologic solutions for
regenerative medicine, announced today the appointment of Cato T.
Laurencin, M.D., Ph.D. to its Board of Directors. Dr. Laurencin joined the
Board of Directors effective September 24, 2008 and will serve on both the
Audit and the Compensation Committees of the Board of Directors.
Kenneth P. Fallon, III, Chairman of the Board of Directors, commented,
"We are excited about the addition of Dr. Laurencin to Osteotech's Board.
Cato's experience and expertise as a nationally prominent orthopaedic
surgeon will be of great assistance in helping the Board support the
Company's new product development initiatives furthering its long-term
growth objectives."
Since August 2008, Dr. Laurencin has been the Vice President for Health
Affairs and the Dean of the School of Medicine at the University of
Connecticut. Dr. Laurencin holds the Albert and Wilda Van Dusen Endowed
Chair in Academic Medicine and is the Distinguished Professor of
Orthopaedic Surgery at the University of Connecticut. Previously, Dr.
Laurencin was the Lillian T. Pratt Distinguished Professor and the Chair of
the Department of Orthopaedic Surgery at the University of Virginia and the
Orthopaedic Surgeon-in-Chief at the University of Virginia Health System.
Dr. Laurencin has been widely published in scholarly journals and holds
more than twenty U.S. patents. He is also a member of the Institute of
Medicine of the National Academy of Sciences.
Osteotech, Inc., headquartered in Eatontown, New Jersey, is a global
leader in providing OsteoBiologic solutions for regenerative medicine to
support surgeons and their patients in the repair of the musculoskeletal
system through the development of innovative therapy-driven products that
alleviate pain, promote biologic healing and restore function. For further
information regarding Osteotech or this press release, please go to
Osteotech's website at http://www.osteotech.com .
SOURCE Osteotech, Inc.
 back to top
Related links:
http://www.osteotech.com
http://www.prnewswire.com/comp/668050.html /
CONTACT:
Mark H. Burroughs of Osteotech, Inc.,
+1-732-542-2800
|
